AVROXA

Technologiepark-Zwijnaarde 82

9052 Gent

BE

AVROXA

Foundation date

10/01/2018

Sector

#Medical Technology

Subsector

AVROXA is a research and manufacturing company committed to the development of innovative solutions based on our versatile proprietary polymer platform technology of poly(2-oxazoline)s (abbreviated as POZ, PAOx,POX). We develop a vast range of high-quality, well-defined, ultra-pure poly(2-oxazoline)s under the brandname ULTROXA(R) for applications in therapeutics, drug delivery, biomaterials and diagnostics.

Upcoming events

Latest news

  • Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board

    1 day ago

  • InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline

    Tuesday March 26th 2024

  • Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy

    Monday March 25th 2024